From Ruth Spates: Hi George, our mixing study procedure requires the patient plasma and the pooled plasma to be incubated separately, and then mixed, and the PT or PTT
Jun 7, 2018 1:32pm
At the World Federation of Hemophilia World Congress, Spark Therapeutics and Pfizer Diagnostics announced factor IX gene transfer vector SPK-9001 success rates in 15 hemophilia B participants. Click or tap here for their press release.
Jun 7, 2018 1:04pm
Precision BioLogic Inc. presented MNBA data at the World Federation of Hemophilia (WFH) 2018 World Congress in Glasgow, Scotland, May 20–24. Recognizing the need to improve factor VIII (FVIII ) inhibitor testing for people with hemophilia A, the company studied the agreement between a chromogenic modified Nijmegen-Bethesda assay (MNBA) and a qualitative ELISA test in the detection of FVIII inhibitors in plasma samples.